Institution: | (1) Department of Neurochemistry, The Institute of Neurology, University College, London, UK;(2) Acute Stroke Program, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford University, Oxford, OX3 9DU, UK;(3) Neurometabolic Unit, National Hospital for Neurology and Neurosurgery (UCLH), Queen Square, London, WC1N 3B, UK;(4) New Use Therapeutics, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, UK |